-
Q1 MedTech quarterly preview: BTIG
-
Deutsche Bank Starts MiniMed Group (MMED) at Buy
-
Goldman Sachs Starts MiniMed Group (MMED) at Buy
-
William Blair Starts MiniMed Group (MMED) at Outperform
-
Evercore ISI Starts MiniMed Group (MMED) at Outperform
-
BTIG Reiterates Buy Rating on MiniMed Group (MMED)
-
Wells Fargo Starts MiniMed Group (MMED) at Overweight
-
Mizuho Starts MiniMed Group (MMED) at Outperform
-
Morgan Stanley Starts MiniMed Group (MMED) at Overweight
-
Citi Starts MiniMed Group (MMED) at Buy
-
Piper Sandler Starts MiniMed Group (MMED) at Neutral
-
MiniMed receives FDA clearance for smartphone-controlled insulin pump
-
MiniMed begins trading on NASDAQ Global Select Market after IPO
-
MiniMed Group (MMED) files for proposed Nasdaq IPO
-
MiniMed Group (MMED) files for proposed IPO

